Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407

Published:2021-11 Issue:11 Volume:16 Page:1883-1892
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Powell Steven F.,Rodríguez-Abreu Delvys,Langer Corey J.,Tafreshi Ali,Paz-Ares Luis,Kopp Hans-Georg,Rodríguez-Cid Jeronimo,Kowalski Dariusz M.,Cheng Ying,Kurata Takayasu,Awad Mark M.,Lin Jinaxin,Zhao Bin,Pietanza M. Catherine,Piperdi Bilal,Garassino Marina C.

Funder

Novartis

AstraZeneca

Roche

Genentech

Celgene

Bristol-Myers Squibb

Boehringer Ingelheim

Eli Lilly and Company

Merck Sharp and Dohme

Merck

MedImmune

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer;Gibson;Med Oncol,2018

2. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases;Ali;Curr Oncol,2013

3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

5. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer;Carbone;N Engl J Med,2017

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial;European Journal of Cancer;2024-11

2. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

3. Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature;Cancers;2024-09-08

4. Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents;Cancer Immunology, Immunotherapy;2024-09-06

5. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3